Antibody-platinum (IV) prodrugs conjugates for targeted treatment of cutaneous squamous cell carcinoma

• Main Authors: Xiangye Yin (Author), Yingjie Zhuang (Author), Haiqin Song (Author), Yujian Xu (Author), Fan Zhang (Author), Jianxin Cui (Author), Lei Zhao (Author), Yingjie Yu (Author), Qixu Zhang (Author), Jun Ye (Author), Youbai Chen (Author), Yan Han (Author)
• Format: Book
• Published: Elsevier, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Antibody-drug conjugates (ADCs) are a new type of targeting antibodies that conjugate with highly toxic anticancer drugs via chemical linkers to exert high specificity and efficient killing of tumor cells, thereby attracting considerable attention in precise oncology therapy. Cetuximab (Cet) is a ty...